title: Soluble HLA-G induces NF-kappaB activation in natural killer cells.
abstract: Human leukocyte antigen (HLA)-G is an immunomodulatory molecule discovered for the first time in the maternal-fetal interface. In cancer context, where high number of natural killer (NK) cells is described, the presence of HLA-G in its soluble form is thought to be essential for NK cells signaling. To evaluate intracellular signaling in NK cells upon HLA-G soluble forms stimulation, we investigate the role of soluble HLA-G (HLA-G5- and HLA-G1 shedding form) stimulation on classical nuclear factor (NF)-kappaB pathway activation. We reported that these two forms of soluble HLA-G could activate NF-kappaB in NK cells. NF-kappaB activation in NK cells does implicate neither phosphatidylinositol 3-kinase (PI3K) nor MEK (MAP kinase kinase) as demonstrated after specific inhibition experiments. We demonstrated elsewhere that NF-kappaB activation in NK cells is not implicated in cytotoxicity inhibition by HLA-G. Our findings may suggest the important role played by NF-kappaB activation after soluble HLA-G stimulation in other NK cells function.
authors.affiliation: Commissariat à l'Energie Atomique, Service de Recherches en Hémato-Immunologie, I2BM, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010 Paris, France. ines.zidi@techemail.com
authors.forename: I
authors.initials: I
authors.lastname: Zidi
authors.forename: C
authors.initials: C
authors.lastname: Guillard
authors.forename: E D
authors.initials: ED
authors.lastname: Carosella
authors.forename: P
authors.initials: P
authors.lastname: Moreau
mesh_terms: D045744:Cell Line, Tumor; D006680:HLA Antigens / Q000378:metabolism*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D007694:Killer Cells, Natural / Q000378:metabolism*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D058539:Phosphatidylinositol 3-Kinase / Q000378:metabolism; D015398:Signal Transduction; D014162:Transfection
chemical_list: D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D016328:NF-kappa B; D058539:Phosphatidylinositol 3-Kinase; D020929:Mitogen-Activated Protein Kinase Kinases
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5207-12
references.pmid: 16549770
references.citation: Int J Biol Markers. 2007 Apr-Jun;22(2):144-53
references.pmid: 17549670
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12150-5
references.pmid: 11572934
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3360-5
references.pmid: 15718280
references.citation: Cell Signal. 2005 Jun;17(6):729-38
references.pmid: 15722197
references.citation: Mol Endocrinol. 2002 Apr;16(4):873-83
references.pmid: 11923482
references.citation: J Immunol. 2006 Mar 1;176(5):3266-76
references.pmid: 16493088
references.citation: Cancer Res. 2005 Nov 15;65(22):10139-44
references.pmid: 16287995
references.citation: Int Immunol. 2007 Apr;19(4):509-22
references.pmid: 17369192
references.citation: J Biol Chem. 1997 Aug 22;272(34):21096-103
references.pmid: 9261113
references.citation: Cell Res. 2005 Mar;15(3):176-82
references.pmid: 15780179
references.citation: Mol Hum Reprod. 2001 Feb;7(2):195-200
references.pmid: 11160846
references.citation: Am J Transplant. 2003 Jan;3(1):11-6
references.pmid: 12492704
references.citation: J Immunol. 2001 Apr 15;166(8):5018-26
references.pmid: 11290782
references.citation: Curr Opin Immunol. 2007 Feb;19(1):46-54
references.pmid: 17142026
references.citation: Proc Natl Acad Sci U S A. 1997 May 13;94(10):5249-54
references.pmid: 9144223
references.citation: Drug News Perspect. 2007 Apr;20(3):155-63
references.pmid: 17520092
references.citation: Hum Immunol. 2003 Nov;64(11):1093-101
references.pmid: 14602240
references.citation: J Exp Med. 1997 Dec 1;186(11):1809-18
references.pmid: 9382880
references.citation: Am J Reprod Immunol. 2001 Feb;45(2):94-9
references.pmid: 11216880
references.citation: Nat Immunol. 2000 Nov;1(5):419-25
references.pmid: 11062502
references.citation: Semin Cancer Biol. 2003 Oct;13(5):361-9
references.pmid: 14708716
references.citation: Mol Immunol. 2008 Jan;45(2):419-27
references.pmid: 17675239
references.citation: Nat Rev Immunol. 2005 Oct;5(10):749-59
references.pmid: 16175180
references.citation: J Biol Chem. 1997 Nov 28;272(48):30412-20
references.pmid: 9374532
references.citation: Cell Mol Life Sci. 2006 Nov;63(22):2669-81
references.pmid: 17072500
references.citation: J Biol Chem. 1998 Feb 6;273(6):3285-90
references.pmid: 9452444
references.citation: Transplant Proc. 2001 May;33(3):2355-9
references.pmid: 11377558
references.citation: PLoS Biol. 2006 Jan;4(1):e9
references.pmid: 16366734
references.citation: Int Immunol. 1999 Aug;11(8):1351-6
references.pmid: 10421792
references.citation: Adv Immunol. 2003;81:199-252
references.pmid: 14711057
references.citation: Biochem Biophys Res Commun. 2004 Jan 16;313(3):606-11
references.pmid: 14697234
references.citation: J Exp Med. 1999 Apr 5;189(7):1093-100
references.pmid: 10190900
references.citation: Eur J Immunol. 2004 Mar;34(3):649-660
references.pmid: 14991594
references.citation: Cancer. 2001 Jul 15;92(2):369-76
references.pmid: 11466692
references.citation: Eur J Immunol. 2001 Feb;31(2):433-9
references.pmid: 11180107
references.citation: Hum Immunol. 2000 Nov;61(11):1177-95
references.pmid: 11137224
references.citation: Mol Cell Biol. 1999 Jul;19(7):4798-805
references.pmid: 10373529
references.citation: Int Immunol. 2001 Oct;13(10):1255-63
references.pmid: 11581170
references.citation: Br J Haematol. 2007 Jul;138(2):202-12
references.pmid: 17593027